NCT00552747View on ClinicalTrials.gov

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

January 31, 2011

Conditions
Coronary Heart DiseaseHyperlipidemia
Interventions
DRUG

fenofibrate

fenofibrate 160 mg capsules qd

DRUG

placebo

capsules placebo

Trial Locations (1)

14080

Endocrinology Department National Institute of Cardiology Ignacio Chavez, Mexico City

All Listed Sponsors
lead

National Heart Institute, Mexico

OTHER_GOV

NCT00552747 - Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease | Biotech Hunter | Biotech Hunter